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Hot numbers in signal transduction
14-3-3 proteins have been known about for a long while but their
functions have been poorly understood; recent results indicate that
they play a role in both signal transduction and the cell cycle.
Occasionally, a series of new findings rekindles interest in
a set of old molecules. 14-3-3 proteins were first de-
scribed 27 years ago in brain extracts as a family of abun-
dant acidic proteins with molecular weights of approx-
imately 30 kD [1]. Since then, more than seven 14-3-3
isoforms have been identified in yeast, plants and inverte-
brates, and a variety of apparently unrelated biological
activities have been ascribed to them. These include acti-
vation of tryptophan and tyrosine hydroxylases [2], regu-
lation of protein kinase C activity [3], stimulation of
calcium-dependent exocytosis [4], and host activation of
an ADP-ribosyltransferase factor of Pseudomonas aerngi-
nosa [5]. Now, several reports suggest that these proteins
play a critical role in signal transduction pathways and in
the cell cycle.
The Ras signal transduction pathway links cell surface
receptors to changes in gene expression through a series
of protein-protein interactions that mediate the so-called
mitogen-activated protein (MAP) kinase cascade. The
role of Ras is to act as a molecular switch such that in
its active GTP-bound conformation it promotes plasma
membrane association of Raf, a cytosolic, serine/threo-
nine kinase [6,7]. Raf then acts as a MAP kinase kinase
kinase to phosphorylate MAP kinase kinase (or MEK),
which in turn phosphorylates MAP kinase, a known
activator of certain transcription factors in the nucleus.
Despite this detailed knowledge of the pathway, the
mechanism by which Raf kinase activity is stimulated
once it reaches the membrane remains unknown.
of the budding yeast Saccharomyces cerevisiae that expresses
mammalian Raf. Freed et al. [8] were able to activate Raf
in this strain by overexpression of 14-3-3, while in com-
plimentary experiments, Irie et al. [11] showed that acti-
vation of Raf by overexpression of Ras is prevented by
deletion of BMH1, which encodes a yeast 14-3-3 homo-
logue. However, the direct activation of recombinant Raf
by 14-3-3 proteins in vitro has not been demonstrated,
and in fact cell-fractionation experiments show that
14-3-3 proteins also interact with inactive, cytosolic Raf
and accompany it to the membrane in response to a Ras
signal [8,10]. It seems likely, therefore, that 14-3-3 acts
as a cofactor that is necessary but not sufficient for Raf
activation (see Fig. 1).
Are 14-3-3 proteins general regulators of kinases? It has
been recognized for some time that protein kinase C
binds to a 14-3-3 isoform (KCIP), also via a cysteine-rich,
zinc-finger like region in its amino-terminal regulatory
Now, a number of groups appear to have found an
important clue to this puzzle [8-11]. Two of the groups
[8,9] have identified, using a yeast two-hybrid screening
assay, the 14-3-3 isotypes 3 and as Raf-binding pro-
teins, while others have shown that 14-3-3 proteins co-
precipitate with Raf from mammalian cell extracts [10].
14-3-3 proteins seem to interact with Raf at multiple
sites, including the zinc-finger like region (CR1) and a
serine/threonine-rich region (CR2), both of which are
within Raf's regulatory amino-terminal domain, but also
within the enzyme's kinase domain (CR3) itself [8-11].
So are the 14-3-3 proteins involved in the activation of
Raf kinase activity? Experiments carried out in both
yeast and animal cells suggest that this is likely. Fantl et al.
[9] have found that 14-3-3 proteins can stimulate
endogenous Raf activity and promote Raf-dependent
maturation when introduced into Xenopus oocytes.
Others have made use of an artificially constructed strain
Fig. 1. Before Ras activation, Raf is bound to 14-3-3 proteins in
the cytosol. Extracellular signals convert Ras to the GTP-bound
form, which functions solely to recruit the Raf-l 4-3-3 complex to
the membrane. Evidence suggests that, in addition to 14-3-3 pro-
teins, another protein (X) - quite possibly a kinase - is needed
for Raf activation at the membrane. One possibility is that 14-3-3
proteins may alter the conformation of Raf at the membrane,
allowing interactions with protein X. Alternatively, 14-3-3 may
provide a scaffold allowing protein X and Raf to interact.
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domain. In this case, 14-3-3 appears to inhibit protein
kinase C activity [3], but other studies indicate that yet
other 14-3-3 isoforms may regulate protein kinase C
translocation to the plasma membrane as part of an activa-
tion mechanism [12]. More recently, 14-3-3 proteins have
been shown to stimulate REKS (for Ras-dependent extra-
cellular-signal-regulated kinase, also known as mitogen-
activated protein kinase kinase stimulator), a distinct but so
far uncharacterized MAP kinase kinase kinase in Xenopus
oocyte cytosol [13]. Finally, Reuther et al. [14] screened
a brain cDNA expression library with a radioactively
labelled domain of the atypical serine/threonine kinase
Bcr, and detected a clone expressing a protein with strong
binding activity that was found to be a 14-3-3 isotype.
The region of Bcr that binds to 14-3-3 proteins is rich in
serine/threonine residues and contains a cysteine-rich
domain reminiscent of those found in protein kinase C
and Raf. Interestingly, the Bcr-Abl fusion protein, found
in the cells of leukaemia patients with the Philadelphia
chromosomal translocation, also interacts with 14-3-3 pro-
teins, and its transforming activity appears to correlate
with its ability to bind 14-3-3. Further support for a role
of the 14-3-3 proteins in signal transduction pathways crit-
ical for growth control comes from the identification of
14-3-3 proteins [15], along with Src, phosphatidylinositol
3-kinase and GRB2, in association with the transforming
middle tumour antigen protein of murine polyomavirus.
One might expect that some of the loss of growth control
in polyomavirus-infected cells may be mediated by the
disregulation of 14-3-3-dependent kinases.
A number of 14-3-3 proteins have been found in yeast
[16,17]. In S. cerevisiae, the 14-3-3 homologue, BMH1,
was found to be non-essential, though gene disruption
leads to impaired growth [16]. Two 14-3-3 homologues,
rad24 and rad25, have recently been identified in the fis-
sion yeast Schizosaccharomyces pombe and shown to play a
role in the timing of mitosis after DNA is replicated [17].
These proteins appear to function as monitors of DNA
damage, ensuring that mitosis does not occur before
repair. This conclusion is supported by the fact that
rad24, and to a lesser extent rad25, null mutants enter
mitosis prematurely following DNA damage; deletion of
both is lethal. The mechanism by which the 14-3-3 pro-
teins regulate this process is not clear at present, though
another checkpoint gene, chkl, appears to be functionally
linked to rad24 and rad25 [18] and this encodes a
serine/threonine kinase. Thus, the 14-3-3 proteins may
play a role in regulating the yeast cell cycle via their
actions on kinase pathways.
Why do the 14-3-3 proteins interact with so many dif-
ferent kinases? One possibility is that cells have recruited
assistants to regulate key kinases such as protein kinase C,
Raf and Bcr, so that multiple signal transduction path-
ways can be simultaneously co-ordinated. Alternatively,
14-3-3 proteins may act independently in these signal
transduction pathways, perhaps as co-factors or scaffolds,
allowing multiple kinases to find each other in an
ordered fashion. It is to be hoped that further analysis of
these regulators will provide new and general insights
into how signal transduction pathways are regulated. In
any case, the recent 'rediscovery' of 14-3-3 proteins rep-
resents a further step towards the goal of describing the
components of the Ras/Raf signalling pathway.
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